| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 12 | 2025 | 460 | 3.570 |
Why?
|
| Lymphocytic Choriomeningitis | 6 | 2022 | 12 | 1.780 |
Why?
|
| Receptors, Glucocorticoid | 5 | 2018 | 104 | 1.520 |
Why?
|
| Programmed Cell Death 1 Receptor | 7 | 2025 | 143 | 1.500 |
Why?
|
| RNA, Long Noncoding | 4 | 2022 | 219 | 1.330 |
Why?
|
| Response Elements | 5 | 2018 | 102 | 1.250 |
Why?
|
| DNA | 5 | 2017 | 1398 | 1.190 |
Why?
|
| Lymphocytic choriomeningitis virus | 5 | 2022 | 15 | 1.020 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2022 | 194 | 0.870 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1305 | 0.770 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 356 | 0.750 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 4 | 2025 | 154 | 0.680 |
Why?
|
| Tumor Microenvironment | 6 | 2025 | 706 | 0.600 |
Why?
|
| Transcriptome | 4 | 2022 | 1097 | 0.590 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 1707 | 0.580 |
Why?
|
| Head and Neck Neoplasms | 4 | 2025 | 635 | 0.560 |
Why?
|
| Conserved Sequence | 2 | 2019 | 277 | 0.550 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2015 | 17 | 0.550 |
Why?
|
| Antigens, CD | 1 | 2019 | 409 | 0.530 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1547 | 0.490 |
Why?
|
| Cell Differentiation | 4 | 2023 | 1906 | 0.490 |
Why?
|
| Neoplasms | 5 | 2022 | 2977 | 0.480 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 1363 | 0.480 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2025 | 137 | 0.470 |
Why?
|
| NF-kappa B | 1 | 2018 | 439 | 0.470 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2016 | 623 | 0.460 |
Why?
|
| Antibodies, Viral | 5 | 2022 | 1171 | 0.430 |
Why?
|
| RNA, Small Nucleolar | 1 | 2014 | 15 | 0.430 |
Why?
|
| Apoptosis | 2 | 2025 | 1826 | 0.410 |
Why?
|
| Receptors, Steroid | 1 | 2014 | 167 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 4691 | 0.380 |
Why?
|
| Mice | 17 | 2025 | 18160 | 0.350 |
Why?
|
| Animals | 23 | 2025 | 33660 | 0.350 |
Why?
|
| Immunologic Memory | 4 | 2022 | 194 | 0.340 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 645 | 0.340 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 534 | 0.320 |
Why?
|
| Glucocorticoids | 1 | 2012 | 345 | 0.320 |
Why?
|
| Antibodies, Neutralizing | 4 | 2022 | 523 | 0.320 |
Why?
|
| HeLa Cells | 3 | 2018 | 689 | 0.310 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 1931 | 0.300 |
Why?
|
| Humans | 32 | 2025 | 130074 | 0.280 |
Why?
|
| Protein Binding | 5 | 2017 | 1649 | 0.280 |
Why?
|
| Crystallography, X-Ray | 4 | 2018 | 364 | 0.280 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2462 | 0.270 |
Why?
|
| Plasma Cells | 2 | 2025 | 54 | 0.250 |
Why?
|
| Binding Sites | 4 | 2021 | 1134 | 0.250 |
Why?
|
| Gene Expression Regulation | 5 | 2022 | 2322 | 0.250 |
Why?
|
| Cytokines | 1 | 2012 | 1332 | 0.250 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 3 | 2023 | 14 | 0.240 |
Why?
|
| Transcription Factors | 1 | 2015 | 2400 | 0.240 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 404 | 0.230 |
Why?
|
| Dengue Virus | 2 | 2017 | 135 | 0.230 |
Why?
|
| Protein Structure, Tertiary | 3 | 2017 | 716 | 0.230 |
Why?
|
| Cell Line, Tumor | 7 | 2025 | 3713 | 0.220 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 61 | 0.220 |
Why?
|
| Amino Acid Sequence | 5 | 2016 | 2392 | 0.220 |
Why?
|
| Zika Virus | 2 | 2017 | 148 | 0.220 |
Why?
|
| Models, Molecular | 3 | 2018 | 1060 | 0.220 |
Why?
|
| Base Sequence | 4 | 2017 | 2729 | 0.210 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2025 | 93 | 0.210 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 91 | 0.200 |
Why?
|
| Cisplatin | 1 | 2025 | 274 | 0.200 |
Why?
|
| Molecular Sequence Data | 4 | 2016 | 3464 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2019 | 21 | 0.190 |
Why?
|
| Antigens, Neoplasm | 1 | 2025 | 393 | 0.180 |
Why?
|
| Clone Cells | 1 | 2022 | 152 | 0.180 |
Why?
|
| Interleukin-2 | 1 | 2022 | 235 | 0.180 |
Why?
|
| Allergy and Immunology | 1 | 2021 | 30 | 0.170 |
Why?
|
| Immunity, Humoral | 2 | 2020 | 73 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2025 | 679 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 815 | 0.160 |
Why?
|
| Immunotherapy | 2 | 2023 | 758 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2023 | 285 | 0.160 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2019 | 14 | 0.160 |
Why?
|
| Granzymes | 1 | 2019 | 44 | 0.150 |
Why?
|
| Lymphoid Tissue | 1 | 2020 | 47 | 0.150 |
Why?
|
| Cross Reactions | 2 | 2017 | 158 | 0.150 |
Why?
|
| Papillomaviridae | 1 | 2020 | 179 | 0.150 |
Why?
|
| Viral Envelope Proteins | 2 | 2017 | 155 | 0.150 |
Why?
|
| Mutation | 5 | 2022 | 6067 | 0.150 |
Why?
|
| Synteny | 1 | 2019 | 66 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2025 | 4645 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 109 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2012 | 318 | 0.140 |
Why?
|
| Datasets as Topic | 1 | 2019 | 98 | 0.140 |
Why?
|
| Genes, Retinoblastoma | 1 | 2018 | 22 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2018 | 800 | 0.140 |
Why?
|
| Dengue | 2 | 2017 | 125 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 499 | 0.140 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 42 | 0.140 |
Why?
|
| Nucleic Acids | 1 | 2018 | 25 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 508 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 300 | 0.130 |
Why?
|
| Retinoblastoma | 1 | 2018 | 86 | 0.130 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 71 | 0.130 |
Why?
|
| Interferon-gamma | 1 | 2019 | 542 | 0.130 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 110 | 0.130 |
Why?
|
| Protein Structure, Secondary | 2 | 2014 | 235 | 0.120 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 630 | 0.120 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 218 | 0.120 |
Why?
|
| Saccharomyces | 1 | 2016 | 9 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4639 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 408 | 0.120 |
Why?
|
| Mucous Membrane | 1 | 2016 | 92 | 0.120 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 58 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2016 | 226 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2014 | 583 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 636 | 0.110 |
Why?
|
| Immune System | 1 | 2016 | 99 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2025 | 2008 | 0.110 |
Why?
|
| Substrate Specificity | 1 | 2015 | 287 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2021 | 558 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1800 | 0.110 |
Why?
|
| Pseudohypoaldosteronism | 1 | 2014 | 1 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 1208 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 626 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2018 | 299 | 0.110 |
Why?
|
| Structural Homology, Protein | 1 | 2014 | 27 | 0.110 |
Why?
|
| Stem Cells | 1 | 2019 | 703 | 0.110 |
Why?
|
| Binding, Competitive | 1 | 2014 | 140 | 0.110 |
Why?
|
| Telomere Homeostasis | 1 | 2014 | 48 | 0.100 |
Why?
|
| Lipids | 1 | 2018 | 566 | 0.100 |
Why?
|
| Gene Expression | 2 | 2018 | 1482 | 0.100 |
Why?
|
| Songbirds | 1 | 2014 | 6 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2014 | 229 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 254 | 0.100 |
Why?
|
| Probiotics | 1 | 2016 | 226 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2014 | 422 | 0.090 |
Why?
|
| Female | 11 | 2025 | 70239 | 0.090 |
Why?
|
| Cell Line | 2 | 2018 | 2554 | 0.090 |
Why?
|
| Phosphatidylcholines | 1 | 2012 | 34 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 150 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 1001 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2012 | 148 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2014 | 502 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2014 | 749 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 570 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 3146 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2014 | 475 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1319 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 776 | 0.080 |
Why?
|
| Microbiota | 1 | 2016 | 435 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 426 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3358 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 2597 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 1478 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2014 | 985 | 0.070 |
Why?
|
| Neutralization Tests | 2 | 2021 | 226 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 476 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 883 | 0.070 |
Why?
|
| Chromatin | 2 | 2022 | 499 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 728 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1406 | 0.060 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2025 | 38 | 0.060 |
Why?
|
| Smoke | 1 | 2025 | 79 | 0.050 |
Why?
|
| Male | 4 | 2019 | 64380 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2025 | 336 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2025 | 127 | 0.050 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2022 | 27 | 0.050 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2022 | 4 | 0.050 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2022 | 14 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2022 | 7 | 0.050 |
Why?
|
| CD28 Antigens | 1 | 2022 | 76 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 70 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2022 | 112 | 0.050 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 51 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 316 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 126 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 252 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 323 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 19 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 36 | 0.040 |
Why?
|
| Epigenomics | 1 | 2022 | 181 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 95 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 428 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 345 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 790 | 0.040 |
Why?
|
| Receptors, CXCR5 | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cell Separation | 1 | 2020 | 220 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 124 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2022 | 321 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2019 | 110 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 449 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2330 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 54 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2019 | 62 | 0.040 |
Why?
|
| Phenotype | 2 | 2022 | 4456 | 0.040 |
Why?
|
| Leadership | 1 | 2021 | 246 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 1165 | 0.040 |
Why?
|
| Anaplasia | 1 | 2018 | 6 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 378 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2018 | 49 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 781 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 272 | 0.030 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2017 | 7 | 0.030 |
Why?
|
| Cross Protection | 1 | 2017 | 10 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2017 | 19 | 0.030 |
Why?
|
| South America | 1 | 2017 | 45 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 349 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1052 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 177 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2018 | 589 | 0.030 |
Why?
|
| Culicidae | 1 | 2017 | 74 | 0.030 |
Why?
|
| Vero Cells | 1 | 2016 | 115 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 390 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 235 | 0.030 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 171 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 747 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 977 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 520 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 756 | 0.030 |
Why?
|
| Monocytes | 1 | 2016 | 335 | 0.030 |
Why?
|
| Animal Communication | 1 | 2014 | 2 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 525 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 659 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 765 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1205 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 2191 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2014 | 220 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2885 | 0.020 |
Why?
|
| Haplotypes | 1 | 2014 | 517 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2012 | 32 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 124 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2012 | 147 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 889 | 0.020 |
Why?
|
| Aromatase | 1 | 2010 | 23 | 0.020 |
Why?
|
| Gene Order | 1 | 2010 | 81 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 83 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2548 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 253 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 888 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 10959 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13266 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 15001 | 0.010 |
Why?
|